In patients hospitalized for COVID-19, tocilizumab reduces mortality at 28 d
- PMID: 34724398
- DOI: 10.7326/ACPJ202111160-125
In patients hospitalized for COVID-19, tocilizumab reduces mortality at 28 d
Abstract
WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group; Shankar-Hari M, Vale CL, Godolphin PJ, et al. Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis. JAMA. 2021;326:499-518. 34228774.
Comment on
-
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.JAMA. 2021 Aug 10;326(6):499-518. doi: 10.1001/jama.2021.11330. JAMA. 2021. PMID: 34228774 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources